SPONSOR
Stichting Hemato-Oncologie voor Volwassenen Nederland
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 1, Phase 2
Stichting Hemato-Oncologie voor Volwassenen Nederland is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Acute Myeloid Leukemia, CLL/SLL.
The trial portfolio spans Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Stichting Hemato-Oncologie voor Volwassenen Nederland
How many clinical trials has Stichting Hemato-Oncologie voor Volwassenen Nederland sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Stichting Hemato-Oncologie voor Volwassenen Nederland, of which 2 are actively recruiting participants. These trials cover conditions including Acute Myeloid Leukemia, CLL/SLL. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Stichting Hemato-Oncologie voor Volwassenen Nederland research focus on?
Stichting Hemato-Oncologie voor Volwassenen Nederland clinical trials span Acute Myeloid Leukemia, CLL/SLL. The research pipeline includes Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Stichting Hemato-Oncologie voor Volwassenen Nederland clinical trial?
To participate in a Stichting Hemato-Oncologie voor Volwassenen Nederland trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Stichting Hemato-Oncologie voor Volwassenen Nederland trials with current recruitment status updated daily.
Clinical Trials by Stichting Hemato-Oncologie voor Volwassenen Nederland
NCT07223814 Phase 3
Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia
NCT05791409 Phase 1, Phase 2
Recruiting
Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL
CLL/SLL
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology